Drug Safety and Effectiveness Network (DSEN)
The Drug Safety and Effectiveness Network (DSEN) is being established at CIHR as part of the Government of Canada's Food and Consumer Safety Action Plan (FCSAP). CIHR is collaborating with Health Canada in the development of the Network, together with stakeholders from across Canada. In Canada and worldwide, there are gaps in information on the safety and effectiveness of drugs used in real-world settings. More information is needed on the safety and effectiveness of pharmaceuticals when used by diverse patient populations outside the controlled experimental environment of clinical trials. The key objectives for establishing the DSEN are to increase the available evidence on drug safety and effectiveness available to regulators, policy-makers, health care providers and patients; and, to increase capacity within Canada to undertake high-quality post-market research in this area.
In this section:
